Novavax (NVAX) Fundamental Analysis: Revenue, Earnings & Valuation

5.81 / 10

Netural

Fundamental metrics rate NVAX as neutral, scoring about 5.8/10. Cash‑to‑market and gross profit margin are relatively strong, yet asset‑to‑market and revenue‑to‑market lag. Overall, the company displays modest financial health with limited upside.

Analysis Checks(10/10)

Revenue-MV

Value-0.04

Score3/3

Weight21.06%

1M Return9.51%

Inventory turnover ratio

Value7.20

Score2/3

Weight-0.78%

1M Return-0.56%

Gross profit margin (%)

Value93.50

Score2/3

Weight2.73%

1M Return1.67%

Profit-MV

Value2.81

Score3/3

Weight23.73%

1M Return9.40%

Income tax / Total profit (%)

Value0.42

Score2/3

Weight1.52%

1M Return0.98%

Current assets turnover ratio

Value1.07

Score3/3

Weight15.27%

1M Return7.57%

Fixed assets turnover ratio

Value6.11

Score2/3

Weight0.01%

1M Return0.01%

Cost of sales ratio (%)

Value6.50

Score2/3

Weight-4.96%

1M Return-3.62%

Asset-MV

Value-0.55

Score2/3

Weight29.56%

1M Return13.10%

Cash-MV

Value0.03

Score2/3

Weight11.85%

1M Return6.19%

Is NVAX fundamentally strong?

NVAX scores 5.81/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 39.19% net margin, 3.46 P/E ratio, -11.91 P/B ratio, and 321.14% earnings growth, these metrics solidify its Netural investment rating.